The federal government’s approval of generic drugs and biosimilars is set to kick off the process for the first phase of the government’s $1-billion national biosimilar program, with a decision expected later this year.But it’s not just a question of who gets to make the best drugs for their customers.The federal government also faces a […]
Continue.. Which of these three companies is Canada’s biggest pharmaceutical company?